Katharine Kirkpatrick

792 total citations
14 papers, 274 citations indexed

About

Katharine Kirkpatrick is a scholar working on Molecular Biology, Pharmacology and Physiology. According to data from OpenAlex, Katharine Kirkpatrick has authored 14 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Pharmacology and 5 papers in Physiology. Recurrent topics in Katharine Kirkpatrick's work include Estrogen and related hormone effects (5 papers), Inflammatory mediators and NSAID effects (5 papers) and Telomeres, Telomerase, and Senescence (5 papers). Katharine Kirkpatrick is often cited by papers focused on Estrogen and related hormone effects (5 papers), Inflammatory mediators and NSAID effects (5 papers) and Telomeres, Telomerase, and Senescence (5 papers). Katharine Kirkpatrick collaborates with scholars based in United Kingdom, Australia and United States. Katharine Kirkpatrick's co-authors include Kefah Mokbel, Robert F. Newbold, Stephen A. Bustin, Paul J. Jenkins, W Ogunkolade, Margaret Ghilchik, Gurpreet Singh‐Ranger, Gary M. Clark, Richard H. De Boer and G. Bruce Mann and has published in prestigious journals such as European Journal of Cancer, Breast Cancer Research and Treatment and Breast Cancer Research.

In The Last Decade

Katharine Kirkpatrick

13 papers receiving 263 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katharine Kirkpatrick United Kingdom 8 120 90 80 67 60 14 274
Janet Dell United States 5 117 1.0× 17 0.2× 124 1.6× 63 0.9× 93 1.6× 5 297
Aleksandra Danielak Poland 8 110 0.9× 52 0.6× 67 0.8× 19 0.3× 33 0.6× 12 316
Ryohei Yoshitake Japan 12 108 0.9× 12 0.1× 70 0.9× 29 0.4× 98 1.6× 30 319
Carlos J Maldonado United States 6 122 1.0× 15 0.2× 60 0.8× 95 1.4× 32 0.5× 12 274
Stefania Indaco Italy 7 202 1.7× 26 0.3× 32 0.4× 11 0.2× 69 1.1× 7 317
Zhirui Jiang United States 8 88 0.7× 103 1.1× 26 0.3× 27 0.4× 11 0.2× 14 250
Guang Liu China 8 184 1.5× 55 0.6× 14 0.2× 10 0.1× 88 1.5× 15 332
Ling Cheng China 12 175 1.5× 14 0.2× 39 0.5× 22 0.3× 50 0.8× 24 328
Hung‐Yun Lin Taiwan 8 134 1.1× 13 0.1× 33 0.4× 20 0.3× 78 1.3× 8 331
Valeria Simonelli Italy 10 217 1.8× 74 0.8× 33 0.4× 11 0.2× 35 0.6× 15 357

Countries citing papers authored by Katharine Kirkpatrick

Since Specialization
Citations

This map shows the geographic impact of Katharine Kirkpatrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katharine Kirkpatrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katharine Kirkpatrick more than expected).

Fields of papers citing papers by Katharine Kirkpatrick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katharine Kirkpatrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katharine Kirkpatrick. The network helps show where Katharine Kirkpatrick may publish in the future.

Co-authorship network of co-authors of Katharine Kirkpatrick

This figure shows the co-authorship network connecting the top 25 collaborators of Katharine Kirkpatrick. A scholar is included among the top collaborators of Katharine Kirkpatrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katharine Kirkpatrick. Katharine Kirkpatrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Kirkpatrick, Katharine, et al.. (2012). Does immediate breast reconstruction compromise the delivery of adjuvant chemotherapy?. The Breast. 22(1). 64–69. 13 indexed citations
3.
Kirkpatrick, Katharine, Robert F. Newbold, & Kefah Mokbel. (2004). The mRNA expression of hTERT in human breast carcinomas correlates with VEGF expression. Journal of Carcinogenesis. 3(1). 1–1. 36 indexed citations
4.
Kirkpatrick, Katharine, Robert F. Newbold, & Kefah Mokbel. (2004). There is no correlation between c-Myc mRNA expression and telomerase activity in human breast cancer. PubMed. 1(1). 2–2. 6 indexed citations
5.
Kirkpatrick, Katharine, W Ogunkolade, Stephen A. Bustin, et al.. (2003). hTERT Expression in Human Breast Cancer and Non-Cancerous Breast Tissue: Correlation with Tumour Stage and c-Myc Expression. Breast Cancer Research and Treatment. 77(3). 277–284. 50 indexed citations
6.
Singh‐Ranger, Gurpreet, Katharine Kirkpatrick, Gary M. Clark, & Kefah Mokbel. (2003). Cyclo-oxygenase-2 (COX-2) mRNA expression correlates with progesterone receptor positivity in human breast cancer. Current Medical Research and Opinion. 19(2). 131–134. 16 indexed citations
7.
Singh‐Ranger, Gurpreet, Katharine Kirkpatrick, Gary M. Clark, & Kefah Mokbel. (2003). Cyclo-oxygenase-2 (COX-2) mRNA expression correlates with progesterone receptor positivity in human breast cancer. Current Medical Research and Opinion. 19(2). 131–134. 1 indexed citations
8.
Kirkpatrick, Katharine, W Ogunkolade, Stephen A. Bustin, et al.. (2002). The mRNA Expression of Cyclo-oxygenase-2 (COX-2) and Vascular Endothelial Growth Factor (VEGF) in Human Breast Cancer. Current Medical Research and Opinion. 18(4). 237–241. 75 indexed citations
9.
Mokbel, Kefah & Katharine Kirkpatrick. (2002). Recent Advances in Breast Cancer (the Twenty-fourth San Antonio Breast Cancer Symposium, December, 2001). Current Medical Research and Opinion. 18(1). 26–29. 7 indexed citations
10.
Kirkpatrick, Katharine, et al.. (2002). Telomerase activity and Bcl-2 expression in human breast cancer. European Journal of Surgical Oncology. 28(1). 14–18. 7 indexed citations
11.
Kirkpatrick, Katharine. (2002). mRNA expression of cyclo-oxygenase-2(cox-2) and vascular endothelial growth factor(VEGF)in human breast cancer. European Journal of Cancer. 38(11). S158–S158. 3 indexed citations
12.
Kirkpatrick, Katharine & Kefah Mokbel. (2001). The significance of human telomerase reverse transcriptase (hTERT) in cancer. European Journal of Surgical Oncology. 27(8). 754–760. 56 indexed citations
13.
Kirkpatrick, Katharine, et al.. (2001). The association between cyclo-oxygenase-2 expression and cell proliferation and angiogenesis in human breast cancer. Breast Cancer Research. 3(S1). 3 indexed citations
14.
Kirkpatrick, Katharine, et al.. (2001). The role of subareolar methylene blue in identifying the sentinel node in patients with invasive breast cancer. Breast Cancer Research. 3(S1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Janet Dell Breakdown of academic impact, for papers by Aleksandra Danielak Breakdown of academic impact, for papers by Ryohei Yoshitake Breakdown of academic impact, for papers by Carlos J Maldonado Breakdown of academic impact, for papers by Stefania Indaco Breakdown of academic impact, for papers by Zhirui Jiang Breakdown of academic impact, for papers by Guang Liu Breakdown of academic impact, for papers by Ling Cheng Breakdown of academic impact, for papers by Hung‐Yun Lin Breakdown of academic impact, for papers by Valeria Simonelli
Rankless by CCL
2026